Welcome to the redesigned epilepsy.com
It is now easier and faster than ever to access news, articles and community content. With less clutter and an improved navigation system, your favorite content is now only a click away.
The new features include:
Take control of your epilepsy and seizures. Seizure management has never been easier.
TAKE CONTROL TODAYThe Pipeline Wiki is a resource created and edited by the epilepsy community intended to offer a comprehensive and up-to-date review of every drug or device under development. Our Pipeline Conferences foster relationships and collaboration among scientists, researchers, entrepreneurs, investors, patients, philanthropists and established companies. We hope our Pipeline Wiki will accomplish the same objectives and contribute towards making these exciting ideas a reality as therapies for patients.
admin |
admin Catalyst, CPP-115
Createdat9/2/10 - 1:08 pm
Tx name
CPP-115
Description
GABA transaminase inhibitor
Company
Catalyst
Status
Overview
|
admin Ganaxolone
Createdat9/2/10 - 1:08 pm Philanthropic Funding Provided by: Epilepsy Therapy Project
Tx name
Ganaxolone
Description
Neurosteroid
Company
Marinus
Status
Phase 2
Overview
|
admin MediPro Pharma, MPP-021
Createdat9/2/10 - 1:09 pm Philanthropic Funding Provided by:
Tx name
MPP-021
Description
|
admin MedKura, Inhaled propofol
Createdat9/2/10 - 1:09 pm Philanthropic Funding Provided by: Epilepsy Therapy Project.
Tx name
Inhaled Antiseizure Treatments
Description
Inhaled propofol for treatment of acute seizures
Company
Medkura
Status
|
admin |
admin Neurotherapeutics, NTP 2014
Createdat9/2/10 - 1:10 pm Philanthropic Funding Provided by: Epilepsy Therapy Project.
Tx name
NTP-2014
Description
Novel MOA
Company
Neurotherapeutics
Status
Preclinical
Overview
|
dfried36 Paloma, P529 Dual-TORC inhibitor
Createdat4/12/11 - 8:30 pm
Tx name
P529
Description
Dual TORC inhibitor
Company
Paloma
Status
Overview
|
warren7 Perampanel
Createdat2/1/11 - 1:31 am
Perampanel (E2007)
Summary: Perampanel is a first-in-class AMPA-type glutamate receptor antagonist being developed by Eisai for partial onset seizures. Three global Phase III studies have been completed including 1490 patients, and Eisai indicated...
|
admin |
admin SK Life Sciences, YKP 3089
Createdat9/2/10 - 1:12 pm
Tx name
YKP3089
Description
efficacy for epilepsy, pain, bipolar, anxiety
Company
SK Life Sciences
Status
Overview
|
admin BioLert, Seizure Alert Device
Createdat9/2/10 - 1:13 pm
Tx name
CPP-115
Description
GABA transaminase inhibitor
Company
Catalyst
Status
Overview
|
siappl... CortiFlex Headset
Createdat9/10/10 - 9:48 pm
Tx name
Wireless EEG electrode cap
Description
ANI Headset (Electrode Cap )
Company
Advanced Neurometrics, Inc.
Status
Phase 1
Overview
|
dboison Legacy, Adenosine Implant
Createdat9/8/10 - 9:09 am
Tx name
Adenosine-releasing silk-based brain implants for epilepsy therapy
Description
Adenosine delivery to brain
Company
Legacy Hospital System
Status
Overview
|
admin NeuroVista, Seizure Advisory System
Createdat9/2/10 - 1:14 pm
Tx name
Seizure Advisory System
Description
Implanted device warns when EEG activity signals a likely seizure
Company
NeuroVista
Status
First patient implanted in Australia July 2010
|
warren... SmartWatch by Smart Monitor Corporation
Createdat10/5/10 - 9:57 am Philanthropic Funding Provided by: Epilepsy Therapy Project.
Product Name
SmartWatch
Description
Wearable Seizure detection and alert monitor
Company
Location
Smart...
|
aschulz Visualase, Image-guided Laser Technology for Thermal Ablation
Createdat11/29/11 - 7:15 pm
Tx name
Laser Ablation in Epilectic Foci
Description
Image-guided Laser Technology provides minimally invasive thermal ablation
Company
Visualase
Overview
|
admin Asklepios, galanin gene therapy
Createdat9/2/10 - 1:15 pm Philanthropic Funding Provided by: Epilepsy Therapy Project
Tx name
Galanin
Description
Gene therapy
Company
Asklepios
Status
Pre-clinical
Overview
|
admin CanCog, Canine Model
Createdat9/2/10 - 1:16 pm
Tx name
A Naturally Occurring Dog Model of Epilepsy
Description
Proof of concept testing in dogs with epilepsy; Dog model has value as a translational model prior to human clinical trials because of the genetic...
|
admin Neurologix, NPY gene therapy
Createdat9/2/10 - 1:16 pm
Tx name
NPY gene therapy
Description
In vivo NPY gene transfer allows for high level expression and functional efficacy limited to target region in the temporal lobe
Company
Neurologix
Status
Primate...
|
